Recombinant Human ASGR1/ASGPR1 protein (His Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
432
Accession
P07306-1
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human ASGR1 protein Gln62-Leu291 (Accession# P07306-1) with a His tag at the N-terminus. |
Predicted Molecular Mass | 27.2 kDa |
SDS-PAGE | 32-38 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Asialoglycoprotein receptor (ASGPR), also known as the hepatic galactose/N-acetylglucosamine (GlcNAc) receptor or Ashwell receptor, is a C-type lectin expressed exclusively in hepatic parenchymal cells. ASGPR consists of two subunits, a major subunit (ASGR1, HL-1) and a minor subunit (ASGR2, HL-2), and specifically recognizes terminal β-linked galactose or GlcNAc on circulating glycoproteins or cells. ASGPR plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins that contain terminal galactose or GlcNAc residues.
References:
1.Meier, M. et al. (2000). J. Mol. Biol. 300:857. 2.Rigopoulou EI. et al. (2012). Autoimmun Rev. 12(2):260-9. 3.Weigel, P.H. and J.H.N. Yik (2002). Biochim. Biophys. Acta 1572:341. 4.Meier, M. et al. (2000). J. Mol. Biol. 300:857.